[Tickers Inside] 7 Solid Gainers Over the Last 5 Sessions

Stocks with 5 days of consecutive price advances. If you cannot see this email properly, please click [here]( [marketinside...] --------------------------------------------------------------- Sponsor Message [Did Biden Bet the Future of America on the "Lithium Triangle"?]( [Discover the one company set to break China's grip on lithium.]([aff_i?offer_...] --------------------------------------------------------------- November 1, 2022 From the desk of the Editor (5 Day Gainers Report) Dear Reader, We just identified 7 Five Day Gainers across all US Exchanges. If you are interested in any of these companies, we encourage you to do your own research and due diligence. Keep reading to see what we just uncovered... --------------------------------------------------------------- Sponsor Message ["TAKE THAT, CHINA!" USA Gains in EV Battery Arms Race]( [f49ed5bd-118...](Did you know each electric car battery requires 220 pounds of graphite ñ more than lithium, copper, or aluminum? China enjoyed a "near monopoly" in this vital ingredient... until the U.S. made a blockbuster announcement. Now one little-known company is set to play a crucial role in the booming $7 trillion EV revolution. [Get the full story on this new North American graphite opportunity]( [5381a560-c43...]([aff_i?offer_...] --------------------------------------------------------------- [Actinium Pharmaceuticals, ATNM]( Recent Analyst Action: Yuan Zhi, analyst at B.Riley Financial, reiterates coverage on [Actinium Pharmaceuticals (ATNM)](in the Healthcare sector with a Buy rating and a price target of $18.00 (1 day ago). - Recent Price: $13.52 - Average Analyst Price Target: $30.00 (121.89%) - Market Cap: $341.00M [TipRanks.com]( also reports that [Actinium Pharmaceuticals](currently has 5 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $30.00. The target pricing ranges from a high forecast of $53.00 down to a low forecast of $18.00. [Actinium Pharmaceuticals (ATNM)](’s last closing price was $13.52 which would put the average price target at $30.00. Here are 3rd party ratings for [ATNM](: - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Top 32% (79 out of 250) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Traditional Investing is DEAD]( [e78ca728-b85...](If you are worried about your investment portfolio… drop everything and watch this demo immediately. It reveals how just ONE trade could make you [$1,000 (or more) every month](, even as stocks, cryptocurrencies, and the economy keep crashing. In the next few minutes, I'll walk you through this new step-by-step (nothing held back) so you can start using it today. It's my #1 way of making money right now. [Click here now to watch the demo.]( [5381a560-c43...]( [aff_i?offer_...] --------------------------------------------------------------- [Seres Therapeutics, MCRB]( Recent Analyst Action: Vernon Bernardino, analyst at H.C. Wainwright, reiterates coverage on [Seres Therapeutics (MCRB)](in the Healthcare sector with a Buy rating and a price target of $25.00 (1 month ago). - Recent Price: $8.99 - Average Analyst Price Target: $15.75 (75.19%) - Market Cap: $1.10B [TipRanks.com]( also reports that [Seres Therapeutics](currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $15.75. The target pricing ranges from a high forecast of $25.00 down to a low forecast of $9.00. [Seres Therapeutics (MCRB)](’s last closing price was $8.99 which would put the average price target at $15.75. Here are 3rd party ratings for [MCRB](: - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Sell, Top 18% (45 out of 250) [Click here for chart >>]( -------------------------------------------------------------------------- [Black Diamond Therapeutics, BDTX]( Recent Analyst Action: Zhiqiang Shu, analyst at Berenberg Bank, reiterates coverage on [Black Diamond Therapeutics (BDTX)](in the Healthcare sector with a Buy rating and a price target of $16.00 (2 months ago). - Recent Price: $2.57 - Average Analyst Price Target: $16.00 (522.57%) - Market Cap: $83.94M [TipRanks.com]( also reports that [Black Diamond Therapeutics](currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $16.00. The target pricing ranges from a high forecast of $16.00 down to a low forecast of $16.00. [Black Diamond Therapeutics (BDTX)](’s last closing price was $2.57 which would put the average price target at $16.00. Here are 3rd party ratings for [BDTX](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: sell - Zacks.com: Hold, Top 32% (79 out of 250) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message Market Wizard who predicted all indexes would be negative in 2022 shares shocking new forecast: ["Prepare for Five Years of Famine"]( [Screen+Shot+...]( [Click here]( for the name of the one ticker you need to protect yourself.[5381a560-c43...]([aff_i?offer_...] --------------------------------------------------------------- [Rumble, RUM]( Recent Analyst Action: Tom Forte, analyst at D.A. Davidson, reiterates coverage on [Rumble (RUM)](in the Technology sector with a Buy rating and a price target of $15.00 (1 month ago). - Recent Price: $12.37 - Average Analyst Price Target: $15.00 (21.26%) - Market Cap: $3.40B [TipRanks.com]( also reports that [Rumble](currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $15.00. The target pricing ranges from a high forecast of $15.00 down to a low forecast of $15.00. [Rumble (RUM)](’s last closing price was $12.37 which would put the average price target at $15.00. Here are 3rd party ratings for [RUM](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak buy - Zacks.com: n/a, n/a [Click here for chart >>]( -------------------------------------------------------------------------- [Frontier Group Holdings, ULCC]( Recent Analyst Action: Helane Becker, analyst at Cowen & Co., reiterates coverage on [Frontier Group Holdings (ULCC)](in the Industrial Goods sector with a Buy rating and a price target of $18.00 (5 days ago). - Recent Price: $13.4 - Average Analyst Price Target: $17.43 (30.07%) - Market Cap: $2.85B [TipRanks.com]( also reports that [Frontier Group Holdings](currently has 7 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $17.43. The target pricing ranges from a high forecast of $20.00 down to a low forecast of $13.00. [Frontier Group Holdings (ULCC)](’s last closing price was $13.4 which would put the average price target at $17.43. Here are 3rd party ratings for [ULCC](: - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak buy - Zacks.com: Hold, Top 28% (69 out of 250) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Investors Look to Capitalize on the Budding Green Revolution]( [c581fbef-7c0...](Lithium is the uncontested fuel of the green energy revolution. One little-known small-cap lithium mining company in a renowned South American location has started attracting interest from opportunity-minded investors. [Discover this company's HUGE lithium potential -- before the masses do.]( [5381a560-c43...]( [aff_i?offer_...] --------------------------------------------------------------- [Helix Energy, HLX]( Recent Analyst Action: Gregory Lewis, analyst at BTIG, reiterates coverage on [Helix Energy (HLX)](in the Industrial Goods sector with a Buy rating and a price target of $10.00 (6 days ago). - Recent Price: $7.05 - Average Analyst Price Target: $8.00 (13.48%) - Market Cap: $1.06B [TipRanks.com]( also reports that [Helix Energy](currently has 3 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $8.00. The target pricing ranges from a high forecast of $10.00 down to a low forecast of $7.00. [Helix Energy (HLX)](’s last closing price was $7.05 which would put the average price target at $8.00. Here are 3rd party ratings for [HLX](: - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Top 6% (15 out of 250) [Click here for chart >>]( -------------------------------------------------------------------------- [Zynex, ZYXI]( Recent Analyst Action: Adam Maeder, analyst at Piper Sandler, reiterates coverage on [Zynex (ZYXI)](in the Healthcare sector with a Hold rating and a price target of $10.00 (4 days ago). - Recent Price: $12.365 - Average Analyst Price Target: $14.50 (17.27%) - Market Cap: $426.97M [TipRanks.com]( also reports that [Zynex](currently has 3 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $14.50. The target pricing ranges from a high forecast of $21.00 down to a low forecast of $10.00. [Zynex (ZYXI)](’s last closing price was $12.365 which would put the average price target at $14.50. Here are 3rd party ratings for [ZYXI](: - TipRanks.com: Moderate Buy - TradingView.com: Strong Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Buy, Bottom 35% (163 out of 250) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [The Biggest "Missing Ingredient" in the $7 Trillion EV Market]( [c732b483-3e4...](China has owned the graphite market for decades. But the U.S. just added graphite to a list of super-critical minerals... "essential for America's National Defense." Perfect timing for a "made in America" graphite company looking to mine, manufacture, and recycle graphite for the booming electric car market. [Don't Miss Your Opportunity to Benefit from This Breaking News]( [5381a560-c43...]([aff_i?offer_...] --------------------------------------------------------------- And there you have it--7 Five Day Gainers across all US Exchanges. Sincerely, The Editor, MarketInsidersPress.com Market Insider Press Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. MarketInsidersPress.com part of Sandpiper Marketing Group, LLC 165 Lockerbie Lane | Mooresville NC | 28115 MarketInsidersPress.com part of Sandpiper Marketing Group, LLC | 1519 Mecklenburg Hwy | Unit 4 | Mount Mourne | NC | 28123 | United States | 877-411-9808 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software